Skip to main content

Advertisement

SpringerLink
Log in

Cytokines and juvenile idiopathic arthritis

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Cytokines are a large group of polypeptides and small proteins that are effector molecules for cells involved in immune and inflammatory responses. There are agonists and antagonists that interact with each other to maintain a dynamic equilibrium, and ensure eventual recovery of any perturbation, for example, by trauma or infection, of the network toward inflammation. The imbalance between pro- and anti-inflammatory cytokines and the T helper cell subtypes is considered important in the pathogenesis of autoimmune diseases, including juvenile idiopathic arthritis. The measurement of cytokines and chemotactic cytokines in body fluids and synovial tissue has provided insight into the type of immune and inflammatory reaction and the possible presence or absence of regulation. Differences between subtypes of juvenile idiopathic arthritis have been identified with these measurements. But cytokine measurements in serum are not useful for diagnostic purposes, because of the variability during 24 hours, the collection and assay methods, as well as the ease of degradation for most cytokines. The recent interest in the genetic polymorphisms of cytokine genes and their association with juvenile idiopathic arthritis has provided association with a number of cytokine alleles. Confirmation of linkage with disease is only available for tumor necrosis factor and interleukin-6 at present. These genetic variants may be the basis of genetic susceptibility to the persistent imbalance in the inflammatory and immune networks, and determine the phenotype and severity of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996, 383:787–793.

    Article  PubMed  CAS  Google Scholar 

  2. Katz JD, Benoist C, Mathis D:T helper cell subsets in insulin-dependent diabetes. Science 1995, 268:1185–1188.

    Article  PubMed  CAS  Google Scholar 

  3. Miller SD, McRae BL, Vanderlugt CL, et al.: Evolution of the T-cell repertoire during the course of experimental immunemediated demyelinating diseases. Immunol Rev 1995, 144:225–244.

    Article  PubMed  CAS  Google Scholar 

  4. Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS: Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol 1995, 155:5029–5037.

    PubMed  CAS  Google Scholar 

  5. Scola MP, Thompson SD, Brunner HL, et al.: Interferongamma: interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 2002, 29:369–378. This is the first study showing type 1 cytokine expression in synovial tissues of juvenile arthritis.

    PubMed  CAS  Google Scholar 

  6. Gattorno M, Facchetti P, Ghiotto F, et al.:Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype. Clin Exp Immunol 1997, 109:4–11.

    Article  PubMed  CAS  Google Scholar 

  7. Wedderburn LR, Robinson N, Patel A, et al.: Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000, 43:765–774. This paper described, for the first time, the predominence of type 1 T cells in the synovial fluid expressing the chemokine receptors that enable these cells to interact with the chemotactic cytokines that are produced by monocytes and activated endothelium.

    Article  PubMed  CAS  Google Scholar 

  8. Gattorno M, Picco P, Vignola S, et al.: Serum interleukin 12 concentration in juvenile chronic arthritis. Ann Rheum Dis 1998, 57:425–428.

    Article  PubMed  CAS  Google Scholar 

  9. Murray KJ, Grom AA, Lieuwen D, et al.: Contrasting T cell cytokine profiles in the synovial fluids and tissues of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: significance of IL-4 in restricted disease. J Rheumatol 1998, 25:1388–1398.

    PubMed  CAS  Google Scholar 

  10. Thompson SD, Luyrink LK, Graham TB, et al.: Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4: IFN-gamma mRNA ratios. J Immunol 2001, 166:6899–6906. This paper confirms a previous paper from this lab, which shows evidence of Th2 cells that are capable of regulating the predominant Th1 cells in the synovial tissue.

    PubMed  CAS  Google Scholar 

  11. Raziuddin S, Bahabri S, Al-Dalaan A, et al.: A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function. Clin Immunol Immunopathol 1998, 86:192–198.

    Article  PubMed  CAS  Google Scholar 

  12. Miller LC, Isa S, Vannier E, et al.: Live Borrelia burgdorferi preferentially activate IL-1b gene expression and protein synthesis over IL-1 receptor antagonist. J Clin Invest 1992, 90:906–912.

    Article  PubMed  CAS  Google Scholar 

  13. Harjecek M, Diaz-Cano S, Alman BA, et al.:Prominent expression of mRNA for the proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis. J Rheumatol 2000, 27:497–503.

    Google Scholar 

  14. Rooney M, Varsani H, Martin K, et al.: Tumor necrosis factor alpha and its soluble receptors in juvenile chronic arthritis. Rheumatology 2000, 39:432–438. This paper showed differences in molar ratios of TNF to sTNFR in the synovial fluids of spondyloarthropathies and polyarthritis in children.

    Article  PubMed  CAS  Google Scholar 

  15. De Benedetti F, Massa M, Pignatti P, et al.:Serum soluble interleukin 6 receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1996, 93:2114–2119.

    Google Scholar 

  16. Keul R, Heinrich P, Muller-Newen G, et al.: A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis. Cytokine 1998, 10:729–734.

    Article  PubMed  CAS  Google Scholar 

  17. Muller K, Herner EB, Stagg A, et al.: Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile rheumatoid arthritis. Br J Rheumatol 1998, 37:562–569.

    Article  PubMed  CAS  Google Scholar 

  18. Pignatti P, Vivarelli M, Meazza C, et al.: Abnormal regulation of interleukin 6 in systemic juvenile idiopathic arthritis. J Rheumatol 2001, 28:1670–1676.

    PubMed  CAS  Google Scholar 

  19. Crawley E, Kon S, Woo P:Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis. Rheumatology 2001, 40:574–578. This paper makes the link between low IL-10 production in the parents of children with extended oligoarthritis, who were shown to have the low producing IL-10 allele in genetic typing (see also reference [50]).

    Article  PubMed  CAS  Google Scholar 

  20. Liprick RN, Sfikakis PP, Klipple GL, et al.: Elevated soluble CD8 antigen and soluble interleukin 2 receptors in the sera of patients with juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1993, 68:64–67.

    Article  Google Scholar 

  21. Madson KL, Moore TL, Lawrence III JM, et al.: Cytokine levels in serum synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994, 21:2359–2363.

    PubMed  CAS  Google Scholar 

  22. Mangge H, Kenzian H, Gallistl S, et al.: Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995, 38:211–220.

    Article  PubMed  CAS  Google Scholar 

  23. Silverman ED, Laxer RM, Nelson DL, et al.: Soluble interleukin 2 receptor in juvenile rheumatoid arthritis. J Rheumatol 1991, 18:1398–1402.

    PubMed  CAS  Google Scholar 

  24. Lepore L, Pennesi M, Saletta S, et al.: Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol 1994, 12:561–565.

    PubMed  CAS  Google Scholar 

  25. Gattorno M, Picco P, Buoncompagni A, et al.:Serum p55 and p75 tumor necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. Ann Rheum Dis 1996, 55:243–247.

    PubMed  CAS  Google Scholar 

  26. De Benedetti F, Pignatti P, Massa M, et al.: Circulating levels of interleukin 1 beta and of interleukin receptor antagonist in systemic juvenile chronic arthritis. Clin Exp Rheumatol 1995, 13:779–784.

    PubMed  Google Scholar 

  27. Prahalad S, Bove KE, Dickens D, et al.: Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 2001, 28:2120–124.

    PubMed  CAS  Google Scholar 

  28. De Benedetti F, Pignatti P, Massa M, et al.: Soluble TNF receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. Br J Rheumatol 1997, 36:581–588.

    Article  PubMed  Google Scholar 

  29. Maeno N, Takei S, Imanaka H, et al.: Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol 1999, 26:2244–2248.

    PubMed  CAS  Google Scholar 

  30. Vignola S, Picco P, Falcini F, et al.: Serum and synovial fluid concentration of vascular endothelial growth factor in juvenile idiopathic arthritides. Rheumatology 2002, 41:691–696.

    Article  PubMed  CAS  Google Scholar 

  31. De Benedetti F, Pignatti P, Bernasconi S, et al.: Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis: relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol 1999, 26:425–431.

    PubMed  Google Scholar 

  32. De Benedetti F, Vivarelli M, Pignatti P, et al.: Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis. J Rheumatol 2000, 27:2246–2250.

    PubMed  Google Scholar 

  33. Meazza C, Travaglino P, Pignatti P, et al.: Macrophage migration inhibition factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:232–237. The first of a series of papers showing the probable role of MIF in JIA.

    Article  PubMed  Google Scholar 

  34. Donn R, Shelley E, Ollier WE, Thomson W:A novel 5’flanking region polymorphism of the macrophage migration inhibitory factor is associate with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001, 44:1782–1785.

    Article  PubMed  CAS  Google Scholar 

  35. Donn R, Alourfi Z, de Benedetti F, et al.: Mutation screening of the macrophage migration inhibitory factor (MIF) gene: positive association of a functional polymorphism of MIP with juvenile idiopathic arthritis. Arthritis Rheum 2002, In press. Migration inhibitory factor is a possible susceptibility gene for JIA.

  36. Mcguire W, Hill AV, Allsopp CE, et al.:Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994, 371:508–510.

    Article  PubMed  CAS  Google Scholar 

  37. eggini E, Thomson W, Kwiatkowski D, et al.: Linkage and association studies of single nucleotide polymorphismtagged tumor necrosis factor haplotypes in juvenile oligiarthritis. Arthritis Rheum 2002, In press. A comprehensive analysis of all the nucleotide variants in the TNF gene, their association with oligoarthritis in a family study, and linkage dysequilibrium between the genetic variants.

  38. Ozen S, Alikasifoglu M, Bakkaloglu A, et al.: Tumor necrosis alpha G>A -238 and G>A -308 polymorphisms in juvenile idiopathic arthritis. Rheumatology 2002, 41:223–227.

    Article  PubMed  CAS  Google Scholar 

  39. Date Y, Seki N, Kamizono S, et al.:Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5’flanking region of the TNF gene and HLA genes. Arthritis Rheum 1999, 42:2577–2582.

    Article  PubMed  CAS  Google Scholar 

  40. Donn RP, Barrett JH, Farham A, et al.: Cytokine gene polymorphisms and susceptibility to juvenile arthritis. Arthritis Rheum 2001, 44:802–810.

    Article  PubMed  CAS  Google Scholar 

  41. Rioux JD, Daly MJ, Silverberg MS, et al.: Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001, 29:223–228.

    Article  PubMed  CAS  Google Scholar 

  42. McDowell TL, Symons JA, Ploski R, et al.: A genetic association between juvenile rheumatoid arthritis and a novel interleukin- 1 alpha polymorphism. Arthritis Rheum 1995, 38:221–228.

    Article  PubMed  CAS  Google Scholar 

  43. Donn RP, Farham AJ, Barrett JH, et al.: Absence of association between interleukin 1alpha and oligoarticular juvenile arthritis in UK patients. Rheumatology 1999, 38:171–175.

    Article  PubMed  CAS  Google Scholar 

  44. Fishman D, Faulds G, Jeffery R, et al.: The effect of novel polymorphisms in the interleukin 6 gene on Il-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369–1376.

    PubMed  CAS  Google Scholar 

  45. Jeffery R, Luong L, Ogilvie E, et al.: : The -174polymorphism of IL-6 alters transcription factor binding and forms functionally significant allelic association in systemic arthritis [abstract]. Rheumatology 2002, 41(suppl):10.

    Google Scholar 

  46. Jahromi MM, Millward BA, Demaine AG: A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type I diabetes mellitus. J Interferon Cytokine Res 2000, 20:885–888.

    Article  PubMed  CAS  Google Scholar 

  47. Ferrari SL, Garnero P, Emond S, et al.:A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum 2001, 44:196–201.

    Article  PubMed  CAS  Google Scholar 

  48. Humphries SE, Luong LA, Ogg MS, et al.: The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001, 22:2243–2252.

    Article  PubMed  CAS  Google Scholar 

  49. Crawley E, Kay R, Sillibourne J, et al.: Polymorphic haplotypes of the interleukin 10 5’flanking region determine variable interleukin 10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999, 42:1101–1108.

    Article  PubMed  CAS  Google Scholar 

  50. Crawley E, Lewis C, Kon S, et al.: A low IL-10 producing genotype is associated with uveitis in JIA, using the transmission disequilibrium test. Rheumatology 2002, In press.

  51. Lim S, Crawley E, Woo P, Barnes PJ: Haplotypes associated with low interleukin-10 production in patients with severe asthma. Lancet 1998, 352:113.

    Article  PubMed  CAS  Google Scholar 

  52. McDermott MF, Aksentijevich I, Gulin J, et al.:Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999, 97:133–144. A landmark paper in the expanding field of gene mutations and recurrent inflammation.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Windeyer Institute of Medical Sciences, Royal Free and University College of London Medical School, University College of London, 46 Cleveland Street, W1T 4JF, London, UK

    Patricia Woo FRCP, FRCPCH, FMedSci

Authors
  1. Patricia Woo FRCP, FRCPCH, FMedSci
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woo, P. Cytokines and juvenile idiopathic arthritis. Curr Rheumatol Rep 4, 452–457 (2002). https://doi.org/10.1007/s11926-002-0050-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-002-0050-9

Keywords

Search

Navigation